Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Bronchial Asthma | Study protocol

Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic

Authors: Adnan Azim, Heena Mistry, Anna Freeman, Clair Barber, Colin Newell, Kerry Gove, Yvette Thirlwall, Matt Harvey, Kimberley Bentley, Deborah Knight, Karen Long, Frances Mitchell, Yueqing Cheng, Judit Varkonyi-Sepp, Wolfgang Grabau, Paddy Dennison, Hans Michael Haitchi, S. Hasan Arshad, Ratko Djukanovic, Tom Wilkinson, Peter Howarth, Ramesh J. Kurukulaaratchy

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

Asthma is now widely recognised to be a heterogeneous disease. The last two decades have seen the identification of a number of biological targets and development of various novel therapies. Despite this, asthma still represents a significant health and economic burden worldwide. Why some individuals should continue to suffer remains unclear.

Methods

The Wessex Asthma Cohort of Difficult Asthma (WATCH) is an ongoing ‘real-life’, prospective study of patients in the University Hospital Southampton Foundation Trust (UHSFT) Difficult Asthma service. Research data capture is aligned with the extensive clinical characterisation required of a commissioned National Health Service (NHS) Specialist Centre for Severe Asthma. Data acquisition includes detailed clinical, health and disease-related questionnaires, anthropometry, allergy and lung function testing, radiological imaging (in a small subset) and collection of biological samples (blood, urine and sputum). Prospective data are captured in parallel to clinical follow up appointments, with data entered into a bespoke database.

Discussion

The pragmatic ongoing nature of the WATCH study allows comprehensive assessment of the real world clinical spectrum seen in a Specialist Asthma Centre and allows a longitudinal perspective of deeply phenotyped patients. It is anticipated that the WATCH cohort would act as a vehicle for potential collaborative asthma studies and will build upon our understanding of mechanisms underlying difficult asthma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Asthma UK. Living on a knife edge. A powerful and moving account of living with serious symptoms of asthma. London: Asthma UK. 2004;1–24. Asthma UK. Living on a knife edge. A powerful and moving account of living with serious symptoms of asthma. London: Asthma UK. 2004;1–24.
3.
go back to reference Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS task force on difficult/therapy-resistant Asthma. European Respiratory Society. Eur Respir J. 1999;13(5):1198–208.PubMed Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS task force on difficult/therapy-resistant Asthma. European Respiratory Society. Eur Respir J. 1999;13(5):1198–208.PubMed
13.
25.
40.
go back to reference Walker SM, Akdis C, Dahlen SE, et al. Building the investment case for asthma R&D: the European Asthma research and innovation partnership argument. Clin Exp Allergy. 2016;46(9):1136–8.CrossRefPubMed Walker SM, Akdis C, Dahlen SE, et al. Building the investment case for asthma R&D: the European Asthma research and innovation partnership argument. Clin Exp Allergy. 2016;46(9):1136–8.CrossRefPubMed
Metadata
Title
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic
Authors
Adnan Azim
Heena Mistry
Anna Freeman
Clair Barber
Colin Newell
Kerry Gove
Yvette Thirlwall
Matt Harvey
Kimberley Bentley
Deborah Knight
Karen Long
Frances Mitchell
Yueqing Cheng
Judit Varkonyi-Sepp
Wolfgang Grabau
Paddy Dennison
Hans Michael Haitchi
S. Hasan Arshad
Ratko Djukanovic
Tom Wilkinson
Peter Howarth
Ramesh J. Kurukulaaratchy
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0862-2

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.